Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) EBIT per Share : E£0.36 (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EBIT per Share?

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT per Share for the three months ended in Mar. 2024 was E£0.10. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was E£0.36.

During the past 12 months, the average EBIT per Share Growth Rate of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents was 30.30% per year. During the past 3 years, the average EBIT per Share Growth Rate was 34.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT per Share or its related term are showing as below:

CAI:RMDA' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 2.8 Med: 17.7 Max: 34
Current: 34

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents was 34.00% per year. The lowest was 2.80% per year. And the median was 17.70% per year.

CAI:RMDA's 3-Year EBIT Growth Rate is ranked better than
80.93% of 860 companies
in the Drug Manufacturers industry
Industry Median: 7.45 vs CAI:RMDA: 34.00

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT for the three months ended in Mar. 2024 was E£144 Mil.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EBIT per Share Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EBIT per Share Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.14

0.16

0.21

0.28

0.35

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.08	0.07	0.11	0.09	0.10

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	518.646	/	1501.459
=	0.35

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	143.701	/	1490.530
=	0.10

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£0.36

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EBIT per Share Related Terms

Thank you for viewing the detailed overview of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY

Website

https://www.ramedapharma.com

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. It is engaged in the manufacture and sale of branded generic pharmaceutical products nutraceuticals, cosmeceuticals, food supplements, medical devices, and veterinary products. The firm is engaged in therapeutic areas namely systemic anti-infectives, alimentary tract and metabolism, genitourinary system and sex hormones, cardiovascular system, nervous system, and blood and blood-forming organs.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Headlines

No Headlines